Low-dose DNMT inhibitors had been reported promoting M1 macrophages to M2 polarization and suppressed excessive inflammation in the acute lung injury, acute myocardial infarction, and atherosclerosis model [33–35]. The gene discussed is DNMT1; the disease is atherosclerosis.